lambertellin: structure in first source
ID Source | ID |
---|---|
PubMed CID | 608228 |
MeSH ID | M0490123 |
Synonym |
---|
lambertellin |
9-hydroxy-3-methylbenzo[g]chromene-2,5,10-trione |
9-hydroxy-3-methyl-2h-naphtho[2,3-b]pyran-2,5,10-trione |
28980-51-0 |
EK3D93687B , |
2h-naphtho(2,3-b)pyran-2,5,10-trione, 9-hydroxy-3-methyl- |
9-hydroxy-3-methyl-2h-benzo[g]chromene-2,5,10-trione # |
WOEURUGFOVZZQQ-UHFFFAOYSA-N |
unii-ek3d93687b |
sucro-neolambertellin |
9-hydroxy-3-methyl-2h-naphtho-(2,3-b)pyran-2,5,10-trione |
Q27895640 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.43) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |